Epiminder (ASX:EPI) EV-to-FCF: 2.61 (As of Jun. 30, 2026)


ASX:EPI Epiminder Ltd ASX:EPI
17 GF Score
Price A$0.32
View Full Analysis

What is Epiminder EV-to-FCF?

Epiminder ASX:EPI +1.59% 17 EV-to-FCF is 2.61 as of Jun. 30, 2026. GuruFocus rates ASX:EPI with a GF Score™ of 17/100. Among 419 Medical Devices & Instruments companies, Epiminder ranks better than 95.47% on this metric.

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Epiminder's Enterprise Value is A$-89.43 Mil. Epiminder's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$-34.30 Mil. Therefore, Epiminder's EV-to-FCF for today is 2.61.

The historical rank and industry rank for Epiminder's EV-to-FCF or its related term are showing as below:

ASX:EPI' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 2.61
Current: 2.61

During the past 3 years, the highest EV-to-FCF of Epiminder was 2.61. The lowest was 0.00. And the median was 0.00.

ASX:EPI's EV-to-FCF is ranked better than
95.47% of 419 companies
in the Medical Devices & Instruments industry
Industry Median: 22.57 vs ASX:EPI: 2.61

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-06-30), Epiminder's stock price is A$0.32. Epiminder's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.254. Therefore, Epiminder's PE Ratio (TTM) for today is At Loss.


Epiminder  (ASX:EPI) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Epiminder's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.32/-0.254
=At Loss

Epiminder's share price for today is A$0.32.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Epiminder's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.254.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Epiminder EV-to-FCF Related Terms


Epiminder EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Epiminder's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epiminder EV-to-FCF Chart

Epiminder Annual Data
Trend Jun23 Jun24 Jun25
EV-to-FCF
0.00 0.00 0.00

Epiminder Semi-Annual Data
Jun23 Jun24 Jun25 Dec25
EV-to-FCF 0.00 0.00 0.00 0.00

ASX:EPI vs ABT, SYK, MDT: EV-to-FCF Comparison

For the Medical Devices subindustry, Epiminder's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epiminder EV-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Epiminder's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Epiminder's EV-to-FCF falls into.


ASX:EPI
17GF Score
Epiminder Ltd ASX:EPI
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Epiminder EV-to-FCF Calculation

Epiminder's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=-89.427/-34.299
=2.61

Epiminder's current Enterprise Value is A$-89.43 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Epiminder's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$-34.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-FCF →
What does a EV-to-FCF of 2.61 mean?
Epiminder (ASX:EPI) has a EV-to-FCF of 2.61 as of Jun. 30, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Epiminder and its competitors. According to the industry distribution chart, Epiminder ranks #19 out of 419 companies in the Medical Devices & Instruments industry, placing it in the top 4.5%.
Is Epiminder's EV-to-FCF too high?
Epiminder's current EV-to-FCF is 2.61. The Medical Devices & Instruments industry median EV-to-FCF is 22.57. Epiminder's value of 2.61 is 88.4% below this industry median. Based on the distribution chart, Epiminder ranks #19 out of 419 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Epiminder has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Epiminder's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Epiminder ranks #19 out of 419 companies for EV-to-FCF. This places Epiminder in the top 5% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 22.57. Epiminder's value of 2.61 is 88.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.57, based on 419 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Epiminder's current EV-to-FCF of 2.61 is 88.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Epiminder and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Epiminder's current EV-to-FCF is 2.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epiminder stock overvalued right now?
Epiminder (ASX:EPI) has a current EV-to-FCF of 2.61. The current EV-to-FCF is 2.61 and 88.4% below the Medical Devices & Instruments industry median of 22.57. Epiminder's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Epiminder (ASX:EPI), the current EV-to-FCF is 2.61 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Epiminder Business Description

Address 525 Collins Street, 210 West Podium, Mezzanine 2, Melbourne, VIC, AUS, 3000
Epiminder Ltd is a medical device and information solutions company focused on developing diagnostic and treatment tools for epilepsy. Its system is a sub-scalp device for continuous monitoring of electrographic brain activity and a set of information solutions, providing patients and their healthcare professionals with detailed data over an extended period.
17GF Score

Get the complete analysis for ASX:EPI

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.32
Price